Delivery Order SPE2DR25D9168-SPE2DR26FCRF3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation, demonstrating the contractor's ability to compete effectively in unrestricted...
- The Defense Logistics Agency awarded a $48,462.60 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count packages). The contract, executed on October 31, 2025, with an ultimate completion date of November 3, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award was issued under DMS Pharmaceutical Group's single-award...
- The Defense Logistics Agency issued a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 20 mg on October 27, 2025, with an ultimate completion date of October 28, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, indicating the award was made through unrestricted federal procurement competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in...
- The Defense Logistics Agency awarded a $12,246.58 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 15 mg. This firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and requires fulfillment at the vendor's Park Ridge location. The award carries no set-aside designation, indicating the company competed in...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg with a firm fixed price ceiling value of $24,729.64. The award, issued on October 23, 2025, with an ultimate completion date of October 24, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60 units of the 5 mg tablet form of the pharmaceutical product JAKAFI. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,146.79, was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing as a small business in...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain for 60 tablets of Jakafi 20 mg with a ceiling value of $148,965.28. The award, issued on September 16, 2025, is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. This delivery order carries no set-aside designation and represents a single product...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 26, 2025, for the supply of Jakafi 5 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $12,146.79. The Defense Logistics Agency, a component of the Department of Defense, issued this award without a set-aside designation to support military healthcare supply requirements. This delivery order falls under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $72,880.74 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on September 23, 2025, with an ultimate completion date of September 24, 2025. The delivery order covers JAKAFI 5 mg tablets in a 60-count quantity, a pharmaceutical product supplied to support federal healthcare operations. This award was made without a set-aside designation,...
- SPE2DR25D9168Indefinite Delivery Contract
- SPE2DR25D9168-SPE2DR26FCRF3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 20 mg tablets (60-count units). This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and does not utilize a set-aside designation. The award reflects DMS Pharmaceutical Group's competitive capability to deliver specialized pharmaceutical products in an unrestricted procurement environment, with the place of performance designated as Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $500 million ceiling value and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products—including branded and generic prescription drugs, biologics, and medical consumables—to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders positions the company as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 10/29/25 |